Bundling: A new frontier in home care
Home care providers are reviewing their business models and considering new pricing structures and methods of service delivery.
In February 2017 a number of important reforms to home care packages were implemented, which reflected the continuing drive of the Australian Government to increase consumer choice and control. These reforms included the allocation of home care packages directly to consumers who are now able to select their provider of choice by directing their package to them.
In anticipation of these reforms, we looked at what makes a good home care agreement and how a good agreement can assist providers to clearly and concisely communicate their value proposition to prospective consumers. As part of this, we noted that service differentiation and communicating an attractive offering will be important in the increasingly competitive market for the delivery of home care services.
Over the past months we have seen home care providers responding to this changing commercial and regulatory landscape by reviewing their business models and considering new pricing structures and methods of service delivery.
This includes the delivery of care and services to a consumer on a ‘bundled’ basis. In broad terms, this involves the consumer electing to receive from their provider a ‘bundle’ of pre-determined care and support services each month which are consistent with their needs and goals.
Learn more about the potential issues regarding the delivery of care and services on a bundled basis.
Learn more about the Maddocks Home Care Agreement for home care packages.
Full Court finds Swiss-style claims invalid – hypothesis as prior art and obviousness of invention
By Ben Miller & Sophie Vo
Clarifies the law on the construction, infringement and novelty of “Swiss-style” patent claims in Mylan v Sun Pharma.
Cautionary tales from the advertising of therapeutic goods during the COVID 19 pandemic
By Angela Wood & Sophie Vo
The active enforcement of the therapeutic goods advertising framework during the COVID-19 pandemic.
Optical Superstores: what does it mean for healthcare and allied health practices?
Implications on commercial arrangements in healthcare involving revenue sharing.
Competition law issues in the merger of Mylan and Pfizer’s Upjohn division
By Steven Tang & Oliver Wahlstrom
The competition law issues arising in the merger of Mylan and Pfizer’s Upjohn division.